hepatitis C

1 Biotech Punished by Hep-C Overreaction
Motley Fool
Sat, 02/18/12 - 12:40 pm
Gilead Sciences
hepatitis C
GS-7977
Big Pharma's Newest Interest
Motley Fool
Sat, 02/18/12 - 12:12 pm
hepatitis C
Achillion, Vertex rally on Gilead's woes
Marketwatch
Fri, 02/17/12 - 01:17 pm
Vertex
Gilead
Achillion
GS-7977
protease inhibitors
hepatitis C
Gilead Suffers First Hep C Drug Setback
TheStreet.com
Fri, 02/17/12 - 09:05 am
Gilead
hepatitis C
GS-7977
BioCryst jumps on hepatitis C study
Marketwatch
Wed, 02/15/12 - 01:31 pm
Biocryst
hepatitis C
BCX5191
Drugmakers Seek Deals to Gain Share of Future Hepatitis C Combination Pill
Bloomberg
Wed, 02/15/12 - 08:55 am
M&A
Inhibitex
Indenix
hepatitis C
Bristol-Myers Squibb
Achillion
Gilead, Vertex and the Mystery of Missing Hep C Patients
TheStreet.com
Mon, 02/13/12 - 10:31 am
Vertex
hepatitis C
Gilead
Can Vertex Pharma shares stage a comeback?
Marketwatch
Fri, 02/10/12 - 10:52 am
Vertex Pharmaceuticals
Incivek
hepatitis C
Curing Diseases Makes For a Bad Business Model (Vertex and Hepatitis C)
Motley Fool
Sat, 02/4/12 - 04:37 pm
Vertex Pharmaceuticals
hepatitis C
Incivek
Idenix Falls Casualty to Gilead Hep C Hoopla
TheStreet.com
Fri, 02/3/12 - 11:56 am
Gilead
hepatitis C
Idenix
Vertex Pharma reports 4th-quarter profit as sales of hepatitis C drug Incivek reach $456.8M
Yahoo/AP
Fri, 02/3/12 - 09:46 am
Vertex
hepatitis C
Incivek
earnings
Vertex Falls as Analyst Cuts Sales Estimates on Hepatitis C Pill
Bloomberg
Mon, 01/30/12 - 12:04 pm
Vertex Pharmaceuticals
hepatitis C
Incivek
Hepatitis C Pill Race Makes BioLineRx a Buyout Target: Israel Overnight
Bloomberg
Wed, 01/25/12 - 10:37 am
hepatitis C
BioLineRx
M&A
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race
Xconomy
Tue, 01/24/12 - 10:56 am
Allos
Vertex
hepatitis C
Telaprevir
Incivek
Bristol-Myers’s Hepatitis C Pills Clear Virus Without Interferon in Study
Bloomberg
Wed, 01/18/12 - 05:57 pm
Bristol-Myers Squibb
hepatitis C
interferon
Inhibitex Auction Shows Battle for Hepatitis Drugs
Minyanville
Wed, 01/18/12 - 09:49 am
hepatitis
hepatitis C
Inhibitex
Bristol-Myers Squibb
German Review Panel Sees Added Benefit for J&J Hepatitis C Drug
Bloomberg
Mon, 01/16/12 - 05:18 pm
JNJ
hepatitis C
Germany
Incivo
Telaprevir
Idenix Seeks Partner for Hepatitis C Combination Drug, CEO Renaud Says
Bloomberg
Sat, 01/14/12 - 11:28 am
Idenix
hepatitis C
IDX184
3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
hepatitis C
Anadys
Roche
Gilead
Pharmasset
Bristol-Myers Squibb
Inhibitex
Merck Hepatitis C Drug May `Anchor' Future Worldwide Regimen
Bloomberg
Tue, 01/10/12 - 09:45 am
Merck
hepatitis C
Victrelis

Pages